Updated Jul 16, 2026
Warma Neil K has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Neil K. Warma is the Chief Executive Officer and a Director of ProMIS Neurosciences Inc., a biotechnology company focused on developing antibody therapeutics for neurodegenerative diseases. He has been involved in the company's strategic direction and operations.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-06 | PMN | ProMIS Neurosciences Inc. | A — Grant or award | 6.2K | $12.13 | $75K |
Neil K. Warma is the Chief Executive Officer and a Director of ProMIS Neurosciences Inc., a biotechnology company focused on developing antibody therapeutics for neurodegenerative diseases. He has been involved in the company's strategic direction and operations.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Warma Neil K profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.